MYCN amplification predicts poor outcome of patients with LIN28 negative supratentorial primitive neuroectodermal tumors of the central nervous system (CNS-PNET)

2013 ◽  
Vol 225 (03) ◽  
Author(s):  
M Gessi ◽  
A von Büren ◽  
A Treitzl ◽  
A zur Mühlen ◽  
S Rutkowski ◽  
...  
2014 ◽  
Vol 16 (7) ◽  
pp. 924-932 ◽  
Author(s):  
Marco Gessi ◽  
André O. von Bueren ◽  
Andras Treszl ◽  
Anja zur Mühlen ◽  
Wolfgang Hartmann ◽  
...  

1997 ◽  
Vol 7 (2) ◽  
pp. 765-784 ◽  
Author(s):  
Lucy Balian Rorke ◽  
John Q. Trojanowski ◽  
Virginia MY Lee ◽  
Robert A. Zimmerman ◽  
Leslie N. Sutton ◽  
...  

2001 ◽  
Vol 125 (2) ◽  
pp. 264-266
Author(s):  
Satish Krishnamurthy ◽  
Stephen Kent Powers ◽  
Javad Towfighi

Abstract Primitive neuroectodermal tumors (PNETs) of the central nervous system are uncommon embryonal neoplasms, rarely occurring in adults. Differentiation into specific mesenchymal tissues, such as cartilage, bone, skeletal muscle, smooth muscle, or adipose tissue, is rare. We report a case of a 51-year-old woman with a PNET of cerebrum that showed extensive mature adipose tissue differentiation. This is the second case, to our knowledge, of PNET of cerebrum with adipose tissue elements that has been described.


2011 ◽  
Vol 35 (4) ◽  
pp. 573-582 ◽  
Author(s):  
Marco Gessi ◽  
Prashanth Setty ◽  
Michele Bisceglia ◽  
Anja zur Muehlen ◽  
Libero Lauriola ◽  
...  

1989 ◽  
Vol 1 (2) ◽  
pp. 139-147 ◽  
Author(s):  
Jaclyn A. Biegel ◽  
Lucy B. Rorke ◽  
Roger J. Packer ◽  
Leslie N. Sutton ◽  
Luis Schut ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0151465 ◽  
Author(s):  
Jeroen F. Vermeulen ◽  
Wim van Hecke ◽  
Wim G. M. Spliet ◽  
José Villacorta Hidalgo ◽  
Paul Fisch ◽  
...  

1978 ◽  
Vol 48 (5) ◽  
pp. 741-746 ◽  
Author(s):  
Edward J. Kosnik ◽  
Carl P. Boesel ◽  
Janet Bay ◽  
Martin P. Sayers

✓ A series of 18 primitive neuroectodermal tumors in children (15 cerebral and three spinal) is reported. These are highly malignant neoplasms, both histologically and clinically. They are rapidly growing tumors, with a brief duration of symptoms and a rapidly progressive course. Forty percent of the patients were alive at 6 months, only 10% at 1 year, and all patients had died within 2 years following diagnosis.


Sign in / Sign up

Export Citation Format

Share Document